Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pituitary hyperplasia.

E Horvath1, K Kovacs, B W Scheithauer

  • 1Department of Laboratory Medicine, St. Michael's Hospital, University of Toronto, Ontario, Canada.

Pituitary
|November 18, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression of leukemia inhibitory factor in craniopharyngioma.

Endocrine pathology·2016
Same author

Localization of vascular endothelial growth factor in nontumorous human pituitaries.

Endocrine pathology·2016
Same author

Invasive thymoma metastatic to the cavernous sinus.

Surgical neurology international·2013
Same author

Tumefactive demyelination and glioblastoma: a rare collision lesion.

Clinical neuropathology·2011
Same author

Dysembryoplastic neuroepithelial tumor and calcifying pseudoneoplasms of the neuraxis: a collision of two seizure-associated lesions.

Clinical neuropathology·2011
Same author

Transformation of low grade glioma and correlation with outcome: an NCCTG database analysis.

Journal of neuro-oncology·2010
Same journal

Clinician decision-making in non-functioning pituitary adenomas: an Australian and New Zealand interdisciplinary survey study.

Pituitary·2026
Same journal

Does persistent hyperprolactinemia contribute to bone loss independently of estrogen deficiency in postmenopausal women?

Pituitary·2026
Same journal

Gauze swabbing technique for safe dissection of pituitary tumors.

Pituitary·2026
Same journal

Postoperative changes in circulating brain injury biomarkers in relation to long-term fatigue and cognitive outcomes after surgery for nonfunctioning pituitary adenomas.

Pituitary·2026
Same journal

Pituitary metastasis as an endocrine-neuro-ophthalmologic emergency: clinical red flags and outcomes from a contemporary tertiary-center series.

Pituitary·2026
Same journal

GH responsiveness to corticotropin-releasing hormone identifies corticotroph-like somatotroph adenomas in acromegaly.

Pituitary·2026
See all related articles

Pituitary hyperplasia, a non-cancerous cell growth, can arise from all pituitary cell types. Prolactin cells are most prone to this condition, while somatotroph hyperplasia is rare, often linked to gigantism.

Area of Science:

  • Endocrinology
  • Surgical Pathology
  • Cell Biology

Background:

  • Pituitary hyperplasia involves non-neoplastic enlargement of pituitary cells.
  • Understanding its morphology and cell type origins is crucial for diagnosis.

Purpose of the Study:

  • To review over 25 years of surgical experience with pituitary hyperplasia.
  • To define morphologic forms (diffuse and nodular) and cell type involvement.

Main Methods:

  • Analysis of surgical pituitary material.
  • Review of normal pituitary cell morphology and distribution.
  • Correlation of hyperplasia types with clinical conditions.

Main Results:

  • All pituitary cell types can undergo hyperplasia, with varying frequency and clinical impact.

Related Experiment Videos

  • Lactotroph hyperplasia is common (physiologic in pregnancy/lactation, secondary in pathology).
  • Corticotroph and thyrotroph hyperplasia are infrequent but documented, sometimes mimicking adenomas.

    • Conclusions:

    • Pituitary hyperplasia presents diverse forms and cell involvements.
    • Lactotroph hyperplasia is most common; somatotroph, corticotroph, and thyrotroph forms have specific associations.
    • Distinguishing hyperplasia from adenoma is vital, especially in thyrotroph cases presenting with hyperprolactinemia.